| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $59.1B | $57.1B | $53.7B | $45.0B | $24.6B | $3.4B | $10.9B | $10.5B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $4.7B | $5.1B | $4.2B | $2.3B | $-1.0B | $-2.1B | $0.9B | $0.7B |
| Net Income | $3.4B | $3.1B | $2.6B | $0.7B | $-2.0B | $-1.9B | $0.6B | $0.5B |
| EPS (Basic) | $10.32 | $9.58 | $7.98 | $2.26 | $-6.10 | $-6.39 | $2.54 | $1.71 |
| EPS (Diluted) | $10.20 | $9.45 | $7.89 | $2.23 | $-6.10 | $-25.30 | $2.53 | $1.70 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $76.4B | $74.1B | $71.1B | $67.4B | $68.2B | $59.5B | $52.6B | $44.8B |
| Current Assets | $16.9B | $18.9B | $18.5B | $20.1B | $21.8B | $14.8B | $8.2B | $7.2B |
| Cash & Equivalents | $5.9B | $8.8B | $6.1B | $7.2B | $18.3B | $11.3B | $2.8B | $1.7B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $26.1B | $23.3B | $22.2B | $20.0B | $18.3B | $12.7B | $14.9B | $13.2B |
| Stockholders' Equity | $15.3B | $12.7B | $9.3B | $6.9B | $5.0B | $6.0B | $11.5B | $10.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $8.4B | $9.4B | $6.9B | $6.1B | $2.1B | $-4.1B | $6.9B | — |
| Investing Cash Flow | $-6.3B | $-2.7B | $-6.1B | $-13.8B | $-1.7B | $0.1B | $-4.6B | — |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-4.9B | $-4.2B | $-1.9B | $-3.3B | $6.4B | $13.0B | $-1.3B | — |